Abstract:The role of peripheral adenosine receptors in pain is a controversial issue and seems to be quite different from the roles of spinal and central adenosine receptors. The present study is aimed at clarifying the role of these receptors in peripheral nociception. To clarify this, studies were done on Swiss mice with adenosine receptor agonists and antagonists. Nociceptive behavior was induced by subcutaneous injection of glutamate (10 μmol) into the ventral surface of the hind paw of mice. Statistical analyses were performed by one-way ANOVA followed by the Student-Newman-Keuls post hoc test. Results showed that intraplantar (i.pl.) administration of N6-cyclohexyl-adenosine (CHA), an adenosine A1 receptor agonist, at 1 or 10 μg/paw significantly reduced glutamate-induced nociception (p<0.01 and p<0.001 vs. vehicle, respectively, n=8−10). In contrast, i.pl. injection of hydrochloride hydrate (CGS21680, an adenosine A2A receptor agonist) (1 μg/paw) induced a significant increase in glutamate-induced nociception compared to the vehicle (p<0.05, n=8), while 4-(-2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol (ZM241385, an adenosine A2A receptor antagonist) (20 μg/paw) caused a significant reduction (p<0.05, n=7−8). There were no significant effects on i.pl. administration of four additional adenosine receptor drugs—8-cyclopentyl-1,3-dipropylxanthine (DPCPX, an A1 antagonist, 1–10 μg/paw), N(6)-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine (DPMA, an A2B agonist, 1–100 μg/paw), alloxazine (an A2B antagonist, 0.1–3 μg/paw), and 2-hexyn-1-yl-N(6)-methyladenosine (HEMADO) (an A3 agonist, 1–100 μg/paw) (p>0.05 vs. vehicle for all tests). We also found that prior administration of DPCPX (3 μg/paw) significantly blocked the anti-nociceptive effect of CHA (1 μg/paw) (p<0.05, n=7–9). Similarly, ZM241385 (20 μg/paw) administered prior to CGS21680 (1 μg/paw) significantly blocked CGS21680-induced exacerbation of nociception (p<0.05, n=8). Finally, inosine (10 and 100 μg/paw), a novel endogenous adenosine A1 receptor agonist recently reported by our research group, was also able to reduce glutamate-induced nociception (p<0.001 vs. vehicle, n=7–8). Interestingly, as an A1 adenosine receptor agonist, the inosine effect was significantly blocked by the A1 antagonist DPCPX (3 μg/paw) (p<0.05, n=7−9) but not by the A2A antagonist ZM241385 (10 μg/paw, p>0.05). In summary, these results demonstrate for the first time that i.pl administration of inosine induces an anti-nociceptive effect, similar to that elicited by CHA and possibly mediated by peripheral adenosine A1 receptor activation. Moreover, our results suggest that peripheral adenosine A2A receptor activation presents a pro-nociceptive effect, exacerbating glutamate-induced nociception independent of inosine-induced anti-nociceptive effects.

The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior

Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat

The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice

Differential Effect of Peripheral Glutamate (NMDA, Non-Nmda) Receptor Antagonists on Bee Venom-Induced Spontaneous Nociception and Sensitization

Long-term application of adrenergic agonists modulates nociceptive ion channels

Adenosine-A1 receptor agonist induced hyperalgesic priming type II

Adenosine A1 Receptor Potentiated Glycinergic Transmission in Spinal Cord Dorsal Horn of Rats after Peripheral Inflammation

Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain

The Role of Α2 Adrenoceptor in Mediating Noradrenaline Action in the Ventrolateral Orbital Cortex on Allodynia Following Spared Nerve Injury

Analgesic Action of Adenosine A1 Receptor Involves the Dephosphorylation of Glycine Receptor Α1ins Subunit in Spinal Dorsal Horn of Mice.

Adenosine receptor targets for pain

Differential effects of adenosine A1 receptor on pain-related behavior in normal and nerve-injured rats.

Excitatory synaptic transmission in the spinal substantia gelatinosa is under an inhibitory tone of endogenous adenosine.

Sustained Elevated Adenosine Via ADORA2B Promotes Chronic Pain Through Neuro-immune Interaction.

Influence of adenosine triphosphate-sensitive potassium channel modulator in spinal cord level on analgesic effect of adenosine agonist

Microinjection of an adenosine A1 agonist into the medial pontine reticular formation increases tail flick latency to thermal stimulation

The role of adenosine receptor ligands on inflammatory pain: possible modulation of TRPV1 receptor function

Collaborative action between noradrenergic and serotoninergic systems in peripheral antinociception in mice

Activation of Α2 Adrenoceptors Inhibited NMDA Receptor-Mediated Nociceptive Transmission in Spinal Dorsal Horn of Mice with Inflammatory Pain

A Role of Periaqueductal Grey NR2B-Containing NMDA Receptor in Mediating Persistent Inflammatory Pain